Magnus Isaksson

Magnus Isaksson

Auto-generated profile, based on publicly available information

Magnus Isaksson

Helix, San Mateo, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in Nature
Verified
Journal Article
Open access
PDF file
SKSmruthi Karthikeyan
Smruthi Karthikeyan
JLJoshua I. Levy
Joshua I. Levy
PHPeter De Hoff
Peter De Hoff
GHGreg Humphrey
Greg Humphrey
ABAmanda Birmingham
Amanda Birmingham
RKRob Knight
Rob Knight
As SARS-CoV-2 continues to spread and evolve, detecting emerging variants early is critical for public health interventions. Inferring lineage prevalence by clinical testing is infeasible at scale, especially in areas with limited resources, participation, or testing and/or sequencing capacity, which can also introduce biases1–3. SARS-CoV-2 RNA concentration in wastewater successfully tracks regional infection dynamics and provides less biased abundance estimates than clinical testing4,5. Tracking virus genomic sequences in wastewater would improve community prevalence estimates and detect emerging variants. However, two factors limit wastewater-based genomic surveillance: low-quality sequence data and inability to estimate relative lineage abundance in mixed samples. Here we resolve these critical issues to perform a high-resolution, 295-day wastewater and clinical sequencing effort, in the controlled environment of a large university campus and the broader context of the surrounding county. We developed and deployed improved virus concentration protocols and deconvolution software that fully resolve multiple virus strains from wastewater. We detected emerging variants of concern up to 14 days earlier in wastewater samples, and identified multiple instances of virus spread not captured by clinical genomic surveillance. Our study provides a scalable solution for wastewater genomic surveillance that allows early detection of SARS-CoV-2 variants and identification of cryptic transmission.

4 January 2021 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
ÅSÅse Bjorvatn Sævik
Åse Bjorvatn Sævik
AWAnette B Wolff
Anette B Wolff
SBSigridur Björnsdottir
Sigridur Björnsdottir
KSKaterina Simunkova
Katerina Simunkova
MHMartha Schei Hynne
Martha Schei Hynne
MØMarianne Øksnes
Marianne Øksnes
Background No reliable biomarkers exist to guide glucocorticoid (GC) replacement treatment in autoimmune Addison’s disease (AAD), leading to overtreatment with alarming and persistent side effects or undertreatment, which could be fatal. Objective To explore changes in gene expression following different GC replacement doses as a means of identifying candidate transcriptional biomarkers to guide GC replacement in AAD. Methods Step 1: Global microarray expression analysis on RNA from whole blood before and after intravenous infusion of 100 mg hydrocortisone (HC) in 10 patients with AAD. In 3 of the most highly upregulated genes, we performed real-time PCR (rt-PCR) to compare gene expression levels before and 3, 4, and 6 hours after the HC infusion. Step 2: Rt-PCR to compare expression levels of 93 GC-regulated genes in normal versus very low morning cortisol levels in 27 patients with AAD. Results Step 1: Two hours after infusion of 100 mg HC, there was a marked increase in FKBP5, MMP9, and DSIPI expression levels. MMP9 and DSIPI expression levels correlated with serum cortisol. Step 2: Expression levels of CEBPB, DDIT4, FKBP5, DSIPI, and VDR were increased and levels of ADARB1, ARIDB5, and POU2F1 decreased in normal versus very low morning cortisol. Normal serum cortisol levels positively correlated with DSIPI, DDIT4, and FKBP5 expression. Conclusions We introduce gene expression as a novel approach to guide GC replacement in AAD. We suggest that gene expression of DSIPI, DDIT4, and FKBP5 are particularly promising candidate biomarkers of GC replacement, followed by MMP9, CEBPB, VDR, ADARB1, ARID5B, and POU2F1.


26 August 2021
Verified
Conference Paper
Open access
Rabé AnderssonRabé Andersson
Rabé Andersson
NBNiclas Björsell
Niclas Björsell
MIMagnus Isaksson
Magnus Isaksson
Coronavirus caused pandemics as many viruses did through human history. The current pandemic causes overwhelmed healthcare system, locked down cities, and massive fatality among humans. Thus, different robots have been used since the COVID outbreak worldwide to reduce spreading infectious diseases and support frontline healthcare workers. This paper sets out the different robots implemented for hospital, non-hospital use, and possible use that can be deployed amidst the pandemic. A literature survey of versatile robots during COVID-19 is introduced. Roboticists contributed with wheeled and drone robots with various applications to assist medical care systems and society during the ongoing crisis. Pandemics are common throughout human history and difficult to avoid or prevent; thus, we intend to encourage societies, academia, engineers and innovators to invest more in robots that cannot catch the virus and consequently introduce beneficial solutions to fight such pandemic in the future.

4 November 2016
Verified
Book Chapter
Closed access
IHI. Hernández-Neuta
I. Hernández-Neuta
AMA. Mezger
A. Mezger
LML. Moens
L. Moens
CLC. Larsson
C. Larsson
JSJohan A. Stenberg
Johan A. Stenberg
MNMats Nilsson
Mats Nilsson